Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kavita Dave"'
Autor:
Nikolaos Miaris, MD, MSc, Georgia Sarri, MD, PhD, Anne McDermott, BA, Mandy McCurry, BA, Alessandra Verzelloni Sef, MD, PhD, Clarissa Borguezan Daros, MD, John Dunning, MD, PhD, Ulrich Stock, MD, PhD, Felix Chua, MD, PhD, Muhammad Usman, PhD, Chiara Bucciarelli-Ducci, MD, PhD, Kavita Dave, MD, PhD, Vicky Gerovasili, MD, PhD, Nandor Marczin, MD, PhD, Martin Carby, MD, PhD, Anna Reed, MD, PhD, Joyce Wong, MD, PhD
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100599- (2024)
Externí odkaz:
https://doaj.org/article/1b2703944d7e4748a537928d53d95ef7
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/1ecf1ebc14b94aebb0ec3caf9479cc17
Publikováno v:
Shanghai Chest. 7:13-13
Publikováno v:
Chest. 159:93-102
Pulmonary exacerbations (PExs) are significant life events in people with cystic fibrosis (CF), associated with declining lung function, reduced quality of life, hospitalizations, and decreased survival. The adult CF population is increasing worldwid
Publikováno v:
BMJ open respiratory research. 9(1)
There were respiratory consultant post vacancies in 82% of surveyed UK hospitals in 2021. Understanding respiratory trainees’ career intentions is vital to plan and train a future respiratory workforce. In 2020, the British Thoracic Society surveye
Publikováno v:
Transplantation.
Introduction: Airway complications after Lung Transplantation(LTx) include bronchial stenoses which require balloon dilatations and stenting and cause complications such as infection and granulation tissue. Biodegradable stents may provide a safer al
Autor:
Martin Carby, Anna Reed, Kavita Dave, V. Gerovasili, Owais Dar, Roopam Sehajpal, Darius Armstrong-James
Publikováno v:
Transplantation.
Publikováno v:
Adult cystic fibrosis (CF).
Publikováno v:
Cystic Fibrosis-Facts, Management and Advances ISBN: 9781838810733
Cystic fibrosis (CF) is one of the most common indications for lung transplant (LTx) and nearly one-third of the LTx worldwide are performed in people with CF (PwCF). Due to vast developments in diagnostic modalities, antibiotic therapies, and manage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb0dfe96a9b040b21452a54a3fa06f3
https://doi.org/10.5772/intechopen.94523
https://doi.org/10.5772/intechopen.94523
Autor:
Nicholas J. Simmonds, Kavita Dave, Clare Saunders, R. Dobra, Sandra Scott, Jane C. Davies, Jess Matthews
Publikováno v:
Pediatric Pulmonology. 56
Since the discovery of the gene responsible for cystic fibrosis (CF) in 1989, hopes have been pinned on a future with novel therapies tackling the basis of the disease rather than its symptoms. These have become a reality over the last decade with th